Skip to main content
. 2017 Jun 4;2017:3549375. doi: 10.1155/2017/3549375

Table 3.

Association of ABCC4 −1508A>G polymorphism with clinical features, metabolite, and cytokine profiles in asthmatic patients.

Clinical features AA (n = 305) AG/GG (n = 48) P value

Age (years) 39.01 ± 14.34 40.92 ± 15.09 0.735
Sex, male (%) 32.14 28.57 0.335
Atopy (%) 57.46 51.18 0.928
Total IgE (IU/mL) 451.48 ± 965.78 278.32 ± 319.68 0.240
Rhinosinusitis (%) 81.21 18.78 0.143
Nasal polyp (%) 81.11 18.88 0.889
FEV1 (%) 86.45 ± 19.66 87.54 ± 14.57 0.638
PC20 methacholine (mg/mL) 10.19 ± 17.07 5.82 ± 8.04 0.119
Total IgE 451.48 ± 965.78 278.32 ± 319.69 0.24
Asthma duration (years) 6.30 ± 6.03 12.81 ± 32.36 0.237

Inflammatory cytokines AA (n = 121) AG/GG (n = 26) P value

MPO (μg/L) 108.26 ± 79.5 150.91 ± 94.13 0.027
IL-8 (pg/mL) 16.82 ± 14.45 14.47 ± 7.5 0.616
IL-18 (pg/mL) 247.77 ± 166.06 281.92 ± 197.10 0.560
Eotaxin-1 (ng/mL) 85.67 ± 63.67 85.22 ± 65.11 0.841
Eotaxin-2 (ng/mL) 1146.92 ± 802.14 1104.95 ± 641.09 0.650
Periostin (ng/mL) 71.07 ± 33.62 91.83 ± 50.85 0.016

Serum metabolites (ng/mL) AA (n = 43) AG/GG (n = 17) P value

15-HETE 265.98 ± 185.69 334.34 ± 132.47 0.195
LTE4 18.22 ± 17 18.8 ± 14.71 0.731
PGF2α 23.55 ± 9.3 21.96 ± 8.69 0.653
TXB2 0.41 ± 0.42 0.39 ± 0.17 0.952
Eoxin C4 4.82 ± 9.5 8.14 ± 11.95 0.224
S1P 111.75 ± 42.16 120.91 ± 42.88 0.419

Urinary metabolites (pmol/mg Cr) AA (n = 23) AG/GG (n = 8) P value

15- HETE 271.91 ± 89.87 332.5 ± 99.31 0.032
LTE4 7648.29 ± 14378.31 2601.73 ± 3043.59 0.616
PGF2α 8618.51 ± 22942.8 1678.71 ± 978.76 0.65
TXB2 5686.61 ± 4305.7 4798.25 ± 3957.21 0.765
Eoxin C4 144.78 ± 94.07 124.75 ± 46.65 0.602
S1P 32.56 ± 8.25 41.5 ± 9.35 0.010

Values were presented as mean ± SD, whereas values were shown as percentage. Cr: creatinine; LTE4: leukotriene E4; PGF2α: prostaglandin F2α; TXB2: thromboxane B2; 15-HETE: 15-hydroxyeicosatetraenoic acid; MPO: myeloperoxidase; S1P: sphingosine-1-phosphate. P value was obtained by logistic regression analysis with age and sex as covariates.